U.S. infant and kids probiotics market by product type, distribution channel and age group: Opportunity Analysis and Industry Forecast, 2019-2026”, the U.S. infant and kids probiotics market size was valued at $119.86 million in 2018 and is projected to reach $215.87 million by 2026, growing at a CAGR of 7.90% from 2019 to 2026.
Probiotics refer to foods/supplements that contain live microorganisms intended to improve the 'good' bacteria in the body. The live bacteria are regarded beneficial for kids’ health since they help to colonize the gut of the infant. In the recent years, increase in adoption of probiotics as dietary supplements for infants has been witnessed. They are usually promoted as aid to gut health. Specifically, for babies and kids, probiotics are conceived helpful for conditions such as diarrhea, infant colic, and allergy. The most common groups of probiotics are Lactobacillus, Bifidobacterium, Streptococcus, and Saccharomyces boulardii. These groups have strain-specific effects, which implies that all these different groups can have different effects on the body. The consumers in North America have gradually become more interested in taking charge of their health through direct action, and unfiltered access to healthcare information has fueled the current surge of interest in probiotics.
Rise in health concerns among parents coupled with efficacy of probiotics in addressing these concerns, lifestyles changes, increase in disposable income, and broadening of the probiotic’s portfolio drive the demand for infant and kids’ probiotics in the U.S. In addition, rise in cost of healthcare sector and emergence of internet age have led to an increase in preference for precautionary healthcare in the U.S., which in turn boost the growth of the market. Furthermore, increase in development of probiotics that cater to the requirements of health-conscious parents fuels the market growth. For instance, manufacturers have introduced probiotics gummies for kids with attributes such as vegan-friendly, no sugar coated, non-GMO, and others, which is expected to increase the adoption of probiotics in millennial parents. However, regulatory issues in the U.S. are complex. Depending on the probiotic product’s projected use, the U.S. Food and Drug Administration (FDA) could regulate it as a dietary supplement, a drug, or a food ingredient. Several probiotics are sold as dietary supplements, which do not necessitate FDA approval prior to their marketing. Unlike Canada and some European countries, the U.S. does not have defined governmental standards for probiotics. This is expected to hamper the growth of the U.S. infant and kids’ probiotics market.
On the contrary, the penetration of infant and kids’ probiotics through online sales channels and e-commerce platforms is growing rapidly. This is due to the convenience offered by online portals, which provide ease of purchase alongside price comparisons, variety of products, and easy product comparison. In addition, the presence of the largest online and offline retailers in the U.S. such as Amazon and Walmart, gives an edge to the probiotic’s manufacturers for greater consumer access and brand awareness. Multiple brands such as Gerber, Culturelle, BioGaia, and others provide access and purchase of their products through online as well as offline platforms. This is anticipated to provide lucrative opportunities for the market expansion.
The report segments the U.S. infant and kids’ probiotic market into product type, distribution channel and age group. Based on product type, the market is classified into liquid, powder, chewable and others. on the basis of distribution channel, the market is bifurcated into retail pharmacies/drug stores, departmental stores, supermarket/hypermarket and e-commerce. Based on age group, the marked is categorized into baby/infant (0-2 years) and kids (2-6 years).
The key players operating in the U.S. infant and kids probiotic market include Gerber Products Company, BioGaia, Metagenics, Inc., i-Health, Inc, Church & Dwight Co., Inc., LoveBug Nutrition Inc., FIT-Bioceuticals ltd., NOW Foods, Mommy’s Bliss, and Mama's Select.
Key benefits for stakeholders
Key Market Segments
By Product Type
By Distribution Channel
By Age Group
Probiotics refer to foods/supplements that contain live microorganisms intended to improve the 'good' bacteria in the body. The live bacteria are regarded beneficial for kids’ health since they help to colonize the gut of the infant. In the recent years, increase in adoption of probiotics as dietary supplements for infants has been witnessed. They are usually promoted as aid to gut health. Specifically, for babies and kids, probiotics are conceived helpful for conditions such as diarrhea, infant colic, and allergy. The most common groups of probiotics are Lactobacillus, Bifidobacterium, Streptococcus, and Saccharomyces boulardii. These groups have strain-specific effects, which implies that all these different groups can have different effects on the body. The consumers in North America have gradually become more interested in taking charge of their health through direct action, and unfiltered access to healthcare information has fueled the current surge of interest in probiotics.
Rise in health concerns among parents coupled with efficacy of probiotics in addressing these concerns, lifestyles changes, increase in disposable income, and broadening of the probiotic’s portfolio drive the demand for infant and kids’ probiotics in the U.S. In addition, rise in cost of healthcare sector and emergence of internet age have led to an increase in preference for precautionary healthcare in the U.S., which in turn boost the growth of the market. Furthermore, increase in development of probiotics that cater to the requirements of health-conscious parents fuels the market growth. For instance, manufacturers have introduced probiotics gummies for kids with attributes such as vegan-friendly, no sugar coated, non-GMO, and others, which is expected to increase the adoption of probiotics in millennial parents. However, regulatory issues in the U.S. are complex. Depending on the probiotic product’s projected use, the U.S. Food and Drug Administration (FDA) could regulate it as a dietary supplement, a drug, or a food ingredient. Several probiotics are sold as dietary supplements, which do not necessitate FDA approval prior to their marketing. Unlike Canada and some European countries, the U.S. does not have defined governmental standards for probiotics. This is expected to hamper the growth of the U.S. infant and kids’ probiotics market.
On the contrary, the penetration of infant and kids’ probiotics through online sales channels and e-commerce platforms is growing rapidly. This is due to the convenience offered by online portals, which provide ease of purchase alongside price comparisons, variety of products, and easy product comparison. In addition, the presence of the largest online and offline retailers in the U.S. such as Amazon and Walmart, gives an edge to the probiotic’s manufacturers for greater consumer access and brand awareness. Multiple brands such as Gerber, Culturelle, BioGaia, and others provide access and purchase of their products through online as well as offline platforms. This is anticipated to provide lucrative opportunities for the market expansion.
The report segments the U.S. infant and kids’ probiotic market into product type, distribution channel and age group. Based on product type, the market is classified into liquid, powder, chewable and others. on the basis of distribution channel, the market is bifurcated into retail pharmacies/drug stores, departmental stores, supermarket/hypermarket and e-commerce. Based on age group, the marked is categorized into baby/infant (0-2 years) and kids (2-6 years).
The key players operating in the U.S. infant and kids probiotic market include Gerber Products Company, BioGaia, Metagenics, Inc., i-Health, Inc, Church & Dwight Co., Inc., LoveBug Nutrition Inc., FIT-Bioceuticals ltd., NOW Foods, Mommy’s Bliss, and Mama's Select.
Key benefits for stakeholders
- This report provides a quantitative analysis of the current trends, estimations, and dynamics of the U.S. infant and kids probiotics market size from 2019 to 2026 to identify the prevailing opportunities in the market.
- A comprehensive analysis of the factors that drive and restrict the market growth is provided.
- An in-depth analysis of the U.S. infant and kids’ probiotics market helps determine the prevailing market opportunities.
- The report includes details of the analysis of the country market, key players, market segments, application areas, and growth strategies.
Key Market Segments
By Product Type
- Powder
- Liquid
- Chewable
- Others
By Distribution Channel
- Retail Pharmacies/Drug Stores
- Departmental Stores
- Supermarket/Hypermarket
- E-commerce
By Age Group
- Baby/Infant
- Kids
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: U. S. INFANT AND KIDS PROBIOTICS MARKET, BY FORM
CHAPTER 5: U. S. INFANT AND KIDS PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL
CHAPTER 6: U. S. INFANT AND KIDS PROBIOTICS MARKET, BY AGE GROUP
CHAPTER 7: COMPETITION LANDSCAPE
Executive Summary
According to this report titled, 'U.S. Infant and Kids Probiotics Market by Product Type, Distribution Channel and Age Group: Opportunity Analysis and Industry Forecast, 2019-2026,' the U.S. infant and kids probiotics market size was valued at $119.86 million in 2018 and is projected to reach $215.87 million by 2026, growing at a CAGR of 7.9% from 2019 to 2026. The liquid segment was the highest contributor in the market and accounted for approximately 34.8% of the total U.S. infant and kids probiotics market share in 2018.Probiotics are microorganisms (live bacteria) present in and on our bodies and have an advantageous effect on our health, such as prevention from diarrhea, eczema, colic, and other such health conditions. There are many different beneficial species (or strains) of bacteria in the human digestive tract (also known as the gut or intestine). Probiotics help maintain a healthy gut in infants and promote overall health & wellness. Consumers in the U.S. have become far more open-minded towards kids’ health and wellbeing, with regard to alternative therapies such as probiotics. The country has many small probiotic distributors, however only a limited number of fermentation facilities. The primary probiotics available in the U.S. include preparations containing Lactobacillus, Bifidobacterium, Streptococcus, and Saccharomyces boulardii. Probiotics for infants and kids are available in several forms, which include powder, liquid, chewable, and others.
A rise in the number of millennial parents in the U.S. is one of the main factors that drives the demand for probiotics for infant and kids, owing to their different approach to parenting than the previous generations. They have a definitive perspective on what is important in products and br ands they buy for themselves as well as their kids. Furthermore, they are also open to newer healthy product options as long as they are well regulated and provide abundant nutrition to infants. This change in consumer behavior and preference drives the growth of the U.S. infant and kids probiotics market. In addition, innovations in the field of probiotics, including the development of vegan friendly, non-GMO, and sugar-free products, enable manufacturers to meet the rise in demand of health-conscious parents. For instance, the baby probiotics br and Culturelle has a probiotic supplement Calm + Comfort (Probiotic + Chamomile Drops), which is said to help reduce fussiness and crying among babies" by supporting baby's digestive health and offering relief from occasional digestive upset. It also comprises of Lactobacillus rhamnosus GG as the probiotic ingredient. This product formulation claims help attract consumers who pay high attention to ingredients and seek quality products.
However, lack of awareness among consumers regarding the effectiveness of infant probiotics is expected to hamper the growth of the market. The lack of complete knowledge among parents regarding the use and benefits of probiotics for kids can cause potential drawback for the U.S. infant and kids probiotics market.
The U.S. infant and kids probiotics market analysis is carried on the basis of product type, distribution channel and age group. Based on product type, the market is classified into liquid, powder, chewable and others. on the basis of distribution channel, the market is bifurcated into retail pharmacies/drug stores, departmental stores, supermarket/hypermarket and e-commerce. Based on age group, the marked is categorized into baby/infant (0-2 years) and kids (2-6 years).
Key findings of the study
- Based on form, the liquid segment accounts for the largest share in the baby food market in 2019, however the chewable segment is expected to grow at the fastest CAGR of 8.9% during the U.S. infant and kids probiotics market forecast period.
- Based on distribution channel, the retail pharmacies/drug stores segment accounts for the larger market share in 2019, while the e-commerce segment is expected to experience growth at the fastest CAGR of 10.7% during the forecast period.
- Based on age group, the baby/infant segment accounts for the larger market share in 2019, however the kids segment is expected to experience growth at the fastest CAGR of 9.2% during the U.S. infant and kids probiotics market forecast period.
The key players operating in the U.S. infant and kids’ probiotics industry include Gerber Products Company, BioGaia, Metagenics, Inc., i-Health, Inc, Church & Dwight Co., Inc., LoveBug Nutrition Inc., FIT-Bioceuticals ltd., NOW Foods, Mommy’s Bliss, and Mama's Select.
Companies Mentioned
- Gerber Products Company
- BioGaia
- Metagenics Inc.
- i-Health Inc
- Church & Dwight Co. Inc.
- LoveBug Nutrition Inc.
- FIT-Bioceuticals ltd.
- NOW Foods
- Mommy’s Bliss
- Mama's Select
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
